Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
about
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progressionA transcriptional repressor co-regulatory network governing androgen response in prostate cancersInterplay between genomic alterations and androgen receptor signaling during prostate cancer development and progressionGenetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse modelsStructures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev: DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND FORMATION.Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5.The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancerAn oncogenic role for ETV1 in melanoma.Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors.A small molecule that binds and inhibits the ETV1 transcription factor oncoproteinPleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase.The ETS family of oncogenic transcription factors in solid tumours.Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene.Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.Transcription factors ER71/ETV2 and SOX9 participate in a positive feedback loop in fetal and adult mouse testis.ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cellsETS transcription factor ERG cooperates with histone demethylase KDM4A.14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth.Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and CaucasiansGenomic and biochemical insights into the specificity of ETS transcription factors.Recent advances in the structural molecular biology of Ets transcription factors: interactions, interfaces and inhibition.Identification of TDRD1 as a direct target gene of ERG in primary prostate cancer.The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.ETV4 and AP1 Transcription Factors Form Multivalent Interactions with three Sites on the MED25 Activator-Interacting Domain.ETV1 positively regulates transcription of tumor suppressor ARF.ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D.TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer.ERG oncogene modulates prostaglandin signaling in prostate cancer cells.Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10.Upregulation of PSMD10 caused by the JMJD2A histone demethylase.Coordinate transcriptional regulation by ERG and androgen receptor in fusion-positive prostate cancers.Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases.MK2 and ETV1 Are Prognostic Factors in Esophageal Adenocarcinomas.A potential common role of the Jumonji C domain-containing 1A histone demethylase and chromatin remodeler ATRX in promoting colon cancer
P2860
Q24313269-97493BA2-9D61-4B09-989D-7343EA5165A4Q24317244-F0994274-CF78-413C-9F5A-34CE590C3AEAQ27022288-F4938A58-0371-46A4-8B66-BC50A0269897Q27311359-964FA5BA-B733-4C21-A526-AAA9CA696F4DQ30373611-DE11AD93-C187-4367-AFC1-B087056304D8Q33558203-4A293490-9662-4FDD-9E36-8B09B710D3BCQ33698635-761328A3-94D1-4D87-9B79-D56ECBD5CB6FQ33756912-D4AED70E-8E2E-4281-88BA-74F37A724830Q33757981-F64FC729-DD98-4E2A-B70C-4D5ED9EF46E5Q34132931-E0DC8106-8F55-4899-90F3-9615880522E5Q34155238-5AD191D2-DBF7-419E-AD4F-DF41A8B6D9E1Q34555986-F1673AD5-92B6-4FBC-9D55-A06A00F0F90EQ34805348-EAA19810-3E7F-4CD6-8ECC-6F06A585003EQ35554127-EDFE14DC-4075-4994-AC62-D0C3910ECD29Q35996105-373FC5ED-4C51-48F5-8D29-0E496D371285Q36078799-D0E6CA13-5E98-490C-8584-E7537354ED37Q36388955-D18AE9AF-0770-4982-A297-B1ED5C684833Q36515134-ED5338C1-9A59-4597-8391-E587A12A0284Q36779605-8CAEC98D-72A0-40E6-BF97-BA7EAB995E3FQ36908878-9A346F31-67F1-45C0-AEBC-0103549B69A4Q37100125-9022AA26-5E70-40F3-A4FA-61752503390FQ37551286-C8CE4D25-C7A1-41C1-AC3F-C9519B45C850Q37702713-E91DF048-025C-4343-AEF8-25B94405FE24Q37872764-B886F825-1633-4274-851E-AFDC2ED94A43Q38180770-596EF831-7986-4E55-8E8B-6EE34E33BA22Q38318517-257EC165-1F3C-43DB-907E-70760D8970BEQ38329840-DD4D7333-0EAC-46F0-BE0B-8D2C853AB968Q38696706-D02E4A57-5FAA-458E-BD1F-B3E9E06FB969Q39071032-4E832BC9-8E18-46E8-9B82-D2C2A2408740Q39132148-93A34377-374F-4E6A-A8D0-1E6D4347C487Q39178242-F4C3CF17-FECC-43AC-BE68-59B18F416693Q39362468-1D665C1C-81AF-4D8D-8744-D20547122428Q39577718-DEA58616-23DB-4000-8ABC-77E6987BDE75Q39616982-5D8584D8-99E7-4200-BAD3-7D306EE72310Q39652309-CA18D2C5-03B3-400B-9300-67C3495FD2E4Q41615123-1BE391A8-6724-4ADB-A972-4BCA27E9BEACQ41824958-1CEC56D0-20DC-45A6-B06B-4037A024F558Q49378728-EC0DA101-0BCE-446B-A864-26589A77467FQ50333545-B724CC86-CDEE-4EAA-B152-DC4AB81007CAQ58572320-5BC3FC5A-82E5-4DF4-AF42-169B66DBF278
P2860
Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Induction of prostatic intraep ...... iant 1/ETS-related protein 81.
@ast
Induction of prostatic intraep ...... iant 1/ETS-related protein 81.
@en
type
label
Induction of prostatic intraep ...... iant 1/ETS-related protein 81.
@ast
Induction of prostatic intraep ...... iant 1/ETS-related protein 81.
@en
prefLabel
Induction of prostatic intraep ...... iant 1/ETS-related protein 81.
@ast
Induction of prostatic intraep ...... iant 1/ETS-related protein 81.
@en
P2093
P2860
P1433
P1476
Induction of prostatic intraep ...... iant 1/ETS-related protein 81.
@en
P2093
Donald J Tindall
George Vasmatzis
Jan M van Deursen
Jan-Marie Munz
Joseph P Grande
Ralf Janknecht
Scott M Dehm
Tae-Dong Kim
P2860
P304
P356
10.1158/0008-5472.CAN-09-0941
P407
P577
2009-09-29T00:00:00Z